You are slowly dying in so many subtle, little ways that you might not even notice. Until you go to a biohacking conference.
Accepted abstracts showcase Nexalin’s proprietary DIFS™ 15 mA 77.5 Hz treatment platform and clinical improvements across anxiety, depression, insomnia and quality of life Data to be presented include ...
Hosted on MSN
The Blue Jackets need a big splash, and should look to another Eastern Conference contender as an example
As the NHL season nears its crux, there are 30 teams sitting at home watching. Many of them are searching for answers to questions, in an effort to be in this position next season. One of those teams ...
Dana Strong also told the Enders TMT Leaders Live conference in London that it is a time for "courageous, big bets" and explained why British stories make cultural and business sense. By Georg Szalai ...
Glen Ellyn, IL – AMAP invites you to submit an abstract for the 2026 AMAP Annual Conference & Workshop, October 19-21, 2026, in Boston, Massachusetts. Submissions are due Thursday, April 24. This year ...
Please Note: The submission website supports the latest version of Chrome, the current and previous release of Firefox, Safari and Microsoft browsers. Cookies and ...
April 7 - U.S. Vice President JD Vance lashed out on Tuesday at what he called "disgraceful" interference by the European Union in an election in Hungary, as he lauded Prime Minister Viktor Orban as ...
Health Affairs is planning a theme in January 2027 that will explore The Path Forward For Public Health. Our June 2024 theme issue on the topic assessed the state of public health after the COVID-19 ...
The Biennial Conference on Chemical Education 2026 (BCCE 2026) is seeking abstract submissions from educators, researchers, and practitioners. This includes for in-person oral presentations and global ...
Undergraduate students are invited to submit their abstracts by March 2 to present a talk or poster on their research or creative endeavors during the 2026 Purdue Spring Undergraduate Research ...
Belzutifan is advancing in RCC, with LITESPARK-011 showing PFS/ORR benefit with lenvatinib post–PD-(L)1, and LITESPARK-022 improving adjuvant DFS with pembrolizumab. Perioperative enfortumab vedotin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results